Rep. David B. McKinley, P.E. (R-W.Va.) was the speaker at this year's annual National Hemophilia Foundation Conference in Washington, D.C. More than 300 advocates for treatments of rare blood disorders attended the event.
"Working together with Members of both parties, Rep. Lois Capps and I have introduced bipartisan legislation that will allow millions of Americans to have access to critical treatments that can save their lives or improve their quality of life," said Rep. McKinley.
"All Americans deserve access to the most advanced medical technology that we are so fortunate to have in the country," added Rep. McKinley.
"Over the past two years, hearing the stories of patients struggling to pay for medications that would dramatically improve their lives has been heartbreaking. Congress can find common ground to help patients who desperately need these treatments."
Patients with conditions ranging from hemophilia and rheumatoid arthritis to lupus and some forms of cancer can benefit from specialty and biologic drugs, but the cost of these drugs prevents access for many Americans.
The Patient Access to Treatments Act (H.R. 460) is co-sponsored by Lois Capps (D-CA) and 15 bipartisan Members of Congress.